Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis.

Kropski JA, Young LR, Cogan JD, Mitchell DB, Lancaster LH, Worrell JA, Markin C, Liu N, Mason WR, Fingerlin TE, Schwartz DA, Lawson WE, Blackwell TS, Phillips Iii JA, Loyd JE.

Am J Respir Crit Care Med. 2016 Oct 27. [Epub ahead of print]

PMID:
27786550
2.

Persistent Lung Disease in Adults with NKX2.1 Mutation and Familial Neuroendocrine Cell Hyperplasia of Infancy.

Nevel RJ, Garnett ET, Worrell JA, Morton RL, Nogee LM, Blackwell TS, Young LR.

Ann Am Thorac Soc. 2016 Aug;13(8):1299-304. doi: 10.1513/AnnalsATS.201603-155BC.

PMID:
27187870
3.

Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.

Kropski JA, Pritchett JM, Zoz DF, Crossno PF, Markin C, Garnett ET, Degryse AL, Mitchell DB, Polosukhin VV, Rickman OB, Choi L, Cheng DS, McConaha ME, Jones BR, Gleaves LA, McMahon FB, Worrell JA, Solus JF, Ware LB, Lee JW, Massion PP, Zaynagetdinov R, White ES, Kurtis JD, Johnson JE, Groshong SD, Lancaster LH, Young LR, Steele MP, Phillips Iii JA, Cogan JD, Loyd JE, Lawson WE, Blackwell TS.

Am J Respir Crit Care Med. 2015 Feb 15;191(4):417-26. doi: 10.1164/rccm.201406-1162OC.

4.

Cost-effectiveness of CT screening in the National Lung Screening Trial.

Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, Naeim A, Church TR, Silvestri GA, Gorelick J, Gatsonis C; National Lung Screening Trial Research Team..

N Engl J Med. 2014 Nov 6;371(19):1793-802. doi: 10.1056/NEJMoa1312547.

5.

Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis.

Drake WP, Richmond BW, Oswald-Richter K, Yu C, Isom JM, Worrell JA, Shipley GR.

Sarcoidosis Vasc Diffuse Lung Dis. 2013 Nov 25;30(3):201-11.

6.

Results of the two incidence screenings in the National Lung Screening Trial.

Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team..

N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962.

7.

Histoplasmomas of uncommon size.

Richmond BW, Worrell JA, Bastarache JA, Gervich DH, Slattery WR, Loyd JE.

Chest. 2013 Jun;143(6):1795-8. doi: 10.1378/chest.12-2071.

PMID:
23732591
8.

Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules.

Pecot CV, Li M, Zhang XJ, Rajanbabu R, Calitri C, Bungum A, Jett JR, Putnam JB, Callaway-Lane C, Deppen S, Grogan EL, Carbone DP, Worrell JA, Moons KG, Shyr Y, Massion PP.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):786-92. doi: 10.1158/1055-9965.EPI-11-0932.

9.

Reduced lung-cancer mortality with low-dose computed tomographic screening.

National Lung Screening Trial Research Team., Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD.

N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873.

10.

Baseline characteristics of participants in the randomized national lung screening trial.

National Lung Screening Trial Research Team., Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, Lynch DA, Marcus PM, Pinsky PF.

J Natl Cancer Inst. 2010 Dec 1;102(23):1771-9. doi: 10.1093/jnci/djq434. Erratum in: J Natl Cancer Inst. 2011 Oct 19;103(20):1560.

11.

The National Lung Screening Trial: overview and study design.

National Lung Screening Trial Research Team., Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ.

Radiology. 2011 Jan;258(1):243-53. doi: 10.1148/radiol.10091808.

12.

Identification of early interstitial lung disease in an individual with genetic variations in ABCA3 and SFTPC.

Crossno PF, Polosukhin VV, Blackwell TS, Johnson JE, Markin C, Moore PE, Worrell JA, Stahlman MT, Phillips JA 3rd, Loyd JE, Cogan JD, Lawson WE.

Chest. 2010 Apr;137(4):969-73. doi: 10.1378/chest.09-0790.

13.

CT virtual endoscopy in the evaluation of large airway disease: review.

Thomas BP, Strother MK, Donnelly EF, Worrell JA.

AJR Am J Roentgenol. 2009 Mar;192(3 Suppl):S20-30; quiz S31-3. doi: 10.2214/AJR.07.7077. Review.

PMID:
19234286
14.

Computed tomography and the idiopathic form of proliferative fibrosing mediastinitis.

Worrell JA, Donnelly EF, Martin JB, Bastarache JA, Loyd JE.

J Thorac Imaging. 2007 Aug;22(3):235-40.

PMID:
17721332
15.

Critical thinking as an outcome of context-based learning among post RN students: a literature review.

Worrell JA, Profetto-McGrath J.

Nurse Educ Today. 2007 Jul;27(5):420-6. Review.

PMID:
16945453
16.

Cultural competency in diagnostic imaging.

Lee FH, Worrell JA.

Acad Radiol. 2005 Feb;12(2):232-6. No abstract available.

PMID:
15721600
17.

Revised curriculum on cardiothoracic radiology for diagnostic radiology residency with goals and objectives related to general competencies.

Collins J, Abbott GF, Holbert JM, Mullan BF, Kazerooni EA, Gotway MB, Ginsberg MS, Lacomis JM, Teague SD, Reddy GP, Worrell JA, Hunsaker A; Education Committee of the Society of Thoracic Radiology..

Acad Radiol. 2005 Feb;12(2):210-23.

PMID:
15721598
18.

Effect of pulmonary edema on tracheal diameter.

Snapper JR, Trochtenberg DS, Hwang YS, Lefferts PL, Carroll FE, Worrell JA, O'Donnell DM.

Respiration. 1999 Nov-Dec;66(6):522-7.

PMID:
10575338
19.

The Hermansky-Pudlak syndrome.

Parker MS, Rosado Shipley W, de Christenson ML, Slutzker AD, Carroll FE, Worrell JA, White JG.

Ann Diagn Pathol. 1997 Dec;1(2):99-103.

PMID:
9869831
20.

AIDS-related bronchogenic carcinoma: fact or fiction?

Parker MS, Leveno DM, Campbell TJ, Worrell JA, Carozza SE.

Chest. 1998 Jan;113(1):154-61.

PMID:
9440583

Supplemental Content

Loading ...
Support Center